CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• EPS Cop. Y/Y Annual
Fibrogen Inc   (NASDAQ: FGEN)
Other Ticker:  
 
 

FGEN's EPS from Cont. Operations Growth by Quarter and Year

Fibrogen Inc 's EPS from Cont. Operations results by quarter and year

 



FGEN EPS from Cont. Operations (in $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter December - 0.00 -0.57 -0.70
3rd Quarter September - -0.17 -0.65 -0.98
2nd Quarter June - -0.16 -0.90 -0.78
1st Quarter March -0.16 -0.33 -0.81 -0.68
FY   -0.16 -0.66 -2.93 -3.14

FGENs Annual EPS from Cont. Operations
Fibrogen Inc 's EPS from Cont. Operations in the fiscal year 2024 $ -1.53
Fibrogen Inc 's EPS from Cont. Operations in the fiscal year 2023 $ -2.92
Fibrogen Inc 's EPS from Cont. Operations in the fiscal year 2022 $ -3.14
Fibrogen Inc 's EPS from Cont. Operations in the fiscal year 2021 $ -3.14
Fibrogen Inc 's EPS from Cont. Operations in the fiscal year 2019 $ -0.89




FGEN EPS from Cont. Operations first quarter 2025 Y/Y Growth Comment
Fibrogen Inc in the first quarter 2025 recorded EPS loss from Cont. Operations of $ -0.16 .

According to the results reported in the first quarter 2025, Fibrogen Inc achieved the best EPS from Cont. Operations growth in Major Pharmaceutical Preparations industry. While Fibrogen Inc ' s EPS from Cont. Operations no change of 0% ranks overall at the positon no. in the first quarter 2025.


FGEN EPS from Cont. Operations ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   - - - -

Financial Statements
Fibrogen Inc 's first quarter 2025 EPS from Cont. Operations $ -0.16 FGEN's Income Statement
Fibrogen Inc 's first quarter 2024 EPS from Cont. Operations $ -0.33 Quarterly FGEN's Income Statement


FGEN EPS from Cont. Operations (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY (Year on Year)   - - - -


Go to FGEN financial reports >> Back to FGEN Growth rate Comparisons >>


EPS from Cont. Operations first quarter 2025 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS from Cont. Operations first quarter 2025 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS from Cont. Operations by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Fibrogen Inc 's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


FGEN's I. Quarter Q/Q EPS from Cont. Operations Comment


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


FGEN's I. Quarter Q/Q EPS from Cont. Operations Comment


Fibrogen Inc 's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Mar 31 2025)		 12 Months Ending
(Dec 31 2024)		 12 Months Ending
(Sep 30 2024)		 12 Months Ending
(Jun 30 2024)		 12 Months Ending
(Mar 31 2024)
Cumulative EPS from Cont. Operations 12 Months Ending $ -0.49 $ -0.66 $ -1.23 $ -1.71 $ -2.45
Y / Y EPS from Cont. Operations Growth (TTM) - - - - -
Year on Year EPS from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential EPS from Cont. Operations Change (TTM) - - - - -
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # # # # #


Cumulative EPS from Cont. Operations growth Comment


Fibrogen Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS from Cont. Operations growth Comment


Fibrogen Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS from Cont. Operations Growth
Major Pharmaceutical Preparations Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
FGEN's EPS from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for FGEN's Competitors
EPS from Cont. Operations Growth for Fibrogen Inc 's Suppliers
EPS from Cont. Operations Growth for FGEN's Customers

You may also want to know
FGEN's Annual Growth Rates FGEN's Profitability Ratios FGEN's Asset Turnover Ratio FGEN's Dividend Growth
FGEN's Roe FGEN's Valuation Ratios FGEN's Financial Strength Ratios FGEN's Dividend Payout Ratio
FGEN's Roa FGEN's Inventory Turnover Ratio FGEN's Growth Rates FGEN's Dividend Comparisons



Companies with similar EPS from Cont. Operations no change for the quarter ending Mar 31 2025 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Mar 31 2025
Steris Plc-3.89%$ -3.887 
Mettler Toledo International Inc-5.31%$ -5.314 
Pfizer Inc-5.45%$ -5.455 
Labcorp Holdings Inc -6.27%$ -6.273 
Abbvie Inc -6.49%$ -6.494 
National Research Corporation-7.41%$ -7.407 
Align Technology inc -9.29%$ -9.286 
Iqvia Holdings Inc -10.13%$ -10.127 
Carlisle Companies Incorporated-11.48%$ -11.485 
Utah Medical Products Inc-15.60%$ -15.596 
Mimedx Group Inc -16.67%$ -16.667 
Ani Pharmaceuticals Inc-16.67%$ -16.667 
Stryker Corp-17.39%$ -17.391 
Embecta Corp -20.00%$ -20.000 
West Pharmaceutical Services Inc -21.02%$ -21.019 
Davita Inc -24.91%$ -24.908 
Envista Holdings Corporation-28.57%$ -28.571 
Dexcom Inc -28.95%$ -28.947 
Corcept Therapeutics Inc-29.63%$ -29.630 
Dariohealth Corp -30.00%$ -30.000 
Insulet Corporation-32.43%$ -32.432 
Biogen Inc -39.11%$ -39.114 
Alkermes Plc -39.13%$ -39.130 
Vertex Pharmaceuticals Inc-40.85%$ -40.845 
Amphastar Pharmaceuticals Inc -41.11%$ -41.111 
Select Medical Holdings Corp-41.33%$ -41.333 
Becton Dickinson And Company-42.16%$ -42.162 
Solventum Corporation-42.34%$ -42.336 
Lantheus Holdings Inc -44.50%$ -44.503 
Pacira Biosciences inc -47.37%$ -47.368 


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com